高級產品經理

Leads Lung Cancer, Renal Cell Carcinoma, and Urothelial Carcinoma in the O+Y portfolio that owns the biggest share of 2027 investment. Calls on chest physicians, thoracic surgeons, urologists, and medical oncologists.

Responsibilities:

1.Defend first-line lung cancer share in a directly contested immunotherapy market

2.Lead peri-operative lung launch preparation, including thoracic surgeon engagement and hospital MDT adoption

3.Partner with Market Access on NHI submission strategy, and with the Alliance Manager on Ono alignment

Requirements:

1.Minimum 3 years as a product manager, with demonstrated ownership of a brand plan and budget

2.Working knowledge of Taiwan NHI reimbursement processes

3.Business-level English

4.Preferred: prior field sales experience in a specialty or hospital setting; oncology or specialty care brand experience.

5.Initiates contact with clinicians and colleagues without prompting, and builds rapport quickly

6.Sustains energy across a launch cycle measured in quarters and manages the pressure